Therapixel
Explore this company’s associated devices, FDA decisions and regulatory history.

Therapixel
- Regulatory records
- 1
- Linked recall entries
- 0
- Headquarters
- Not reported
- Brand website
- Not reported
What the linked records show
MedtechLedger currently links 1 FDA record to the applicant name Therapixel. The collection includes 1 510(k) clearance. These are records held by this publication, rather than a count of the company’s entire portfolio.
The dated entries run from Jun 26, 2026 to Jun 26, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.
Product code QDQ appears in 1 of the 1 linked filings. The collection spans 1 FDA product code. These figures describe the filings available here; they do not establish the company’s total device sales or market share.
Applicant mailing address recorded by FDA: 455 Promenade Des Anglais 06200 Nice - France, Nice, 06200, FR. Recorded on K260714, decision dated Jun 26, 2026.
Device categories in this collection
Radiological Computer Assisted Detection/Diagnosis Software For Lesions Suspicious For Cancer.
Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.
Devices & associated records
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
MammoScreen (5)K260714 | Therapixel | 510(k) clearance | Jun 26, 2026 | FDA |
Source updated Nov 9, 2026. Retrieved Nov 21, 2026.
